Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6469959

COc1cc2nc(Nc3nc(O)c4cc(OCCN5CC(C)OC(C)C5)ccc4n3)nc(C)c2cc1OC.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
ALDH1A1 P00352 6/20 0.41
KDM4E B2RXH2 11/20 0.41
HTT P42858 4/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 2/20 0.37
PSMD14 O00487 1/20 0.37
APAF1 O14727 1/20 0.37
MITF O75030 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
PTK2B Q14289 1/20 0.37
WHR1 P49842 1/20 0.37
EHMT2 Q96KQ7 1/20 0.37
POLB P06746 1/20 0.36
BLM P54132 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6469963 0.89 MEN1 (0.41) MEN1KMT2AALDH1A1KDM4EHTT
Trifluoroacetic Acid SCHEMBL6469150 0.89 RET (0.42) WHR1EHMT2
Trifluoroacetic Acid SCHEMBL6471240 0.88 RET (0.43) ALDH1A1KDM4EWHR1EHMT2
Trifluoroacetic Acid SCHEMBL6469209 0.88 RET (0.43) KDM4EEHMT2
Trifluoroacetic Acid SCHEMBL6467099 0.88 RET (0.40) MEN1KMT2AALDH1A1KDM4EHTT
Trifluoroacetic Acid SCHEMBL6470128 0.87 PDK1 (0.41) MEN1KMT2AALDH1A1KDM4EHTT
Trifluoroacetic Acid SCHEMBL6469205 0.87 KDM4E (0.36) MEN1KMT2AALDH1A1KDM4EHTT
Trifluoroacetic Acid SCHEMBL6469283 0.86 HRH3 (0.39) MEN1KMT2AALDH1A1KDM4EHTT
Trifluoroacetic Acid SCHEMBL6468017 0.86 HSD17B10 (0.40) KDM4EWHR1EHMT2HSD17B10
Trifluoroacetic Acid SCHEMBL6465517 0.86 KDM4E (0.40) MEN1KMT2AALDH1A1KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US claimed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO claimed
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US disclosed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections POLI, POLK, POLB MEN1 4218/4885KMT2A 2156/4885ALDH1A1 3154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.